Reduction of Chlamydophila-felis-associated signs by roxithromycin treatment regimen in cats showing doxycycline intolerance
K. Ploneczka-Janeczko, J. Bania, K. Bierowiec, M. Kielbowicz, Z. Kielbowiczhttps://doi.org/10.17221/8534-VETMEDCitation:Ploneczka-Janeczko K., Bania J., Bierowiec K., Kielbowicz M., Kielbowicz Z. (2015): Reduction of Chlamydophila-felis-associated signs by roxithromycin treatment regimen in cats showing doxycycline intolerance. Veterinarni Medicina, 60: 654-661.
Chlamydophila felis (C. felis) causes chronic conjunctivitis in cats, and is frequently treated with tetracyclines. However, tetracyclines may cause gastrointestinal side effects, such as vomiting, loss of appetite, diarrhoea, and increased liver enzyme activity in some pets. We evaluated the effect of a four-week treatment regimen with roxithromycin – RXM (Rulid® Sanofi-Aventis, France) in 14 cats with conjunctivitis that tested C. felis-positive, and exhibited doxycycline intolerance. The treatment was given for four weeks. Assessment of clinical disease was performed on Day 0 and Day 56. Changes in severity of clinical signs were assessed on a three-step scale (increased, decreased, or no changes) every week of the therapy (Days 7, 14, 21, and 28). Additionally, conjunctival swabs were collected on Days 0 and 56 from each animal, and the C. felis-count was assessed through amplification of the ompA gene by real-time PCR with fluorogenic probes and normalisation to the feline DNA signal. Animals receiving RXM improved regarding the ophtalmological parameters related to manifestation of conjunctivitis, severity of ocular discharge and nasal discharge and breathing patterns (P ≤ 0.05). A visible improvement in relation to these parameters was already observed after two weeks of RXM administration. C. felis-counts decreased in nine cats that were given RXM, but in the other five C. felis was not eliminated. Interestingly, however, aggravation of symptoms was not observed in these five animals. Further studies are needed to fully confirm that a reduction of clinical signs and pathogen counts under conditions of natural infection can be attributed to RXM treatment, since there was no control group that received placebo or another drug in this study. The present results also indicate that in some cases 28 days of RXM administration will not be sufficient to eliminate infection.Keywords:cats; chlamydophilosis; conjunctivitis; alternative therapy; roxythromycin RXMReferences:
Amsden GW (2005): Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of community acquired respiratory tract infection and chronic inflammatory pulmonary conditions? Journal of Antimicrobial Chemotherapy 55, 10–21.Beshir Khalid B, Hallett Rachel L, Eziefula Alice C, Bailey Robin, Watson Julie, Wright Stephen G, Chiodini Peter L, Polley Spencer D, Sutherland Colin J (2010): Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malaria Journal, 9, 312- https://doi.org/10.1186/1475-2875-9-312Chalker Victoria J, Owen Wanda M.A, Paterson Caren J.I, Brownlie Joe (2004): Development of a polymerase chain reaction for the detection of Mycoplasma felis in domestic cats. Veterinary Microbiology, 100, 77-82 https://doi.org/10.1016/j.vetmic.2004.01.014Dean R., Harley R., Helps C., Caney S., Gruffydd-Jones T. (): Use of Quantitative Real-Time PCR To Monitor the Response of Chlamydophila felis Infection to Doxycycline Treatment. Journal of Clinical Microbiology, 43, 1858-1864 https://doi.org/10.1128/JCM.43.4.1858-1864.2005Gerhardt N., Schulz B. S., Werckenthin C., Hartmann K. (2006): Pharmacokinetics of enrofloxacin and its efficacy in comparison with doxycycline in the treatment of Chlamydophila felis infection in cats with conjunctivitis. Veterinary Record, 159, 591-594 https://doi.org/10.1136/vr.159.18.591GERMAN A, CANNON M, DYE C, BOOTH M, PEARSON G, REAY C, GRUFFYDDJONES T (2005): Oesophageal strictures in cats associated with doxycycline therapy. Journal of Feline Medicine & Surgery, 7, 33-41 https://doi.org/10.1016/j.jfms.2004.04.001Hartmann A.D., Helps C.R., Lappin M.R., Werckenthin C., Hartmann K. (2008): Efficacy of Pradofloxacin in Cats with Feline Upper Respiratory Tract Disease due to Chlamydophila felis or Mycoplasma Infections. Journal of Veterinary Internal Medicine, 22, 44-52 https://doi.org/10.1111/j.1939-1676.2007.0012.xHartmann Anja D., Hawley Jennifer, Werckenthin Christiane, Lappin Michael R., Hartmann Katrin (2010): Detection of bacterial and viral organisms from the conjunctiva of cats with conjunctivitis and upper respiratory tract disease. Journal of Feline Medicine & Surgery, 12, 775-782 https://doi.org/10.1016/j.jfms.2010.06.001Helps C., Reeves N., Egan K., Howard P., Harbour D. (2003): Detection of Chlamydophila felis and Feline Herpesvirus by Multiplex Real-Time PCR Analysis. Journal of Clinical Microbiology, 41, 2734-2736 https://doi.org/10.1128/JCM.41.6.2734-2736.2003Koopaei Mona Noori, Maghazei Mohamad Shahab, Mostafavi Seyed Hossein, Jamalifar Hossein, Samadi Nasrin, Amini Mohsen, Malek Soheyl Jafari, Darvishi Behrad, Atyabi Fatemeh, Dinarvand Rassoul (2012): Enhanced antibacterial activity of roxithromycin loaded pegylated poly lactide-co-glycolide nanoparticles. DARU Journal of Pharmaceutical Sciences, 20, 92- https://doi.org/10.1186/2008-2231-20-92Krayenbuehl Pierre-Alexandre, Wiesli Peter, Maly Friedrich E., Vetter Wilhelm, Schulthess Georg (2005): Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment. Atherosclerosis, 179, 103-110 https://doi.org/10.1016/j.atherosclerosis.2004.08.031Livak Kenneth J., Schmittgen Thomas D. (2001): Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method. Methods, 25, 402-408 https://doi.org/10.1006/meth.2001.1262Marsilio F, Di Martino B, Di Francesco C (2004): Use of a duplex-PCR assay to screen for feline herpesvirus-1 and Chlamydophila spp. in mucosal swabs from cats. New Microbiologica 27, 287–292.Nakano T, Ohashi Y, Tanaka A, Kakinoki Y, Washio Y, Nakai Y (1998): Roxythromycin reinforces epithelial defence function in rabbit trachea. Acta Oto-Laryngologica 538 (Suppl.), 233–238.OWEN W, STURGESS C, HARBOUR D, EGAN K, GRUFFYDDJONES T (2003): Efficacy of azithromycin for the treatment of feline chlamydophilosis. Journal of Feline Medicine & Surgery, 5, 305-311 https://doi.org/10.1016/S1098-612X(03)00072-XPadovan Jasna, Ralić Jovica, Letfus Vatroslav, Milić Astrid, Bencetić Mihaljević Vlatka (2012): Investigating the barriers to bioavailability of macrolide antibiotics in the rat. European Journal of Drug Metabolism and Pharmacokinetics, 37, 163-171 https://doi.org/10.1007/s13318-011-0074-5Preac-Mursic V., Wilske B., Schierz G., Süß E., Groß B. (1989): Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferi. European Journal of Clinical Microbiology & Infectious Diseases, 8, 651-653 https://doi.org/10.1007/BF01968150Sandoz Kelsi M, Rockey Daniel D (2010): Antibiotic resistance in Chlamydiae. Future Microbiology, 5, 1427-1442 https://doi.org/10.2217/fmb.10.96Schulz B. S., Hupfauer S., Ammer H., Sauter-Louis C., Hartmann K. (): Suspected side effects of doxycycline use in dogs - a retrospective study of 386 cases. Veterinary Record, 169, 229-229 https://doi.org/10.1136/vr.d4344Schulz B. S., Zauscher S., Ammer H., Sauter-Louis C., Hartmann K. (): Side effects suspected to be related to doxycycline use in cats. Veterinary Record, 172, 184-184 https://doi.org/10.1136/vr.101031Steel Helen C., Theron Annette J., Cockeran Riana, Anderson Ronald, Feldman Charles (2012): Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics. Mediators of Inflammation, 2012, 1-17 https://doi.org/10.1155/2012/584262Stephens Richard S., Myers Garry, Eppinger Mark, Bavoil Patrik M. (2009): Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunology & Medical Microbiology, 55, 115-119 https://doi.org/10.1111/j.1574-695X.2008.00516.xSturgess C. P., Gruffydd-Jones T. J., Harbour D. A., Jones R. L. (2001): Controlled study of the efficacy of clavulanic acid-potentiated amoxycillin in the treatment of Chlamydia psittaci in cats. Veterinary Record, 149, 73-76 https://doi.org/10.1136/vr.149.3.73Sugiura Y, Ohashi Y, Nakai Y (1997a): Roxythromycin stimulates the mucociliary activity of the Eustachian Tube and modulates neuthrophil activity in the healthy guinea pigs. Acta Oto-Laryngologica 531 (Suppl.), 34–38.Sugiura Y, Ohashi Y, Nakai Y (1997b): Roxythromycin prevents endotoxin-induced otitis media with effusion in guinea pigs. Acta Oto-Laryngologica 531 (Suppl.), 39–51.Sykes Jane E. (2005): Feline Chlamydiosis. Clinical Techniques in Small Animal Practice, 20, 129-134 https://doi.org/10.1053/j.ctsap.2004.12.018Tamaoki Jun, Kadota Junichi, Takizawa Hajime (2004): Clinical implications of the immunomodulatory effects of macrolides. The American Journal of Medicine Supplements, 117, 5-11 https://doi.org/10.1016/j.amjmed.2004.07.023Worm A M, Hoff G, Kroon S, Petersen C S, Christensen J J (1989): Roxithromycin compared with erythromycin against genitourinary chlamydial infections.. Sexually Transmitted Infections, 65, 35-38 https://doi.org/10.1136/sti.65.1.35Wyrick P. B. (2004): Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. Journal of Antimicrobial Chemotherapy, 54, 79-85 https://doi.org/10.1093/jac/dkh283